Page last updated: 2024-11-02

pamidronate and Muscle Disorders

pamidronate has been researched along with Muscle Disorders in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Pamidronate at 60 mg was compared with pamidronate at 10 mg rather than placebo in view of the high incidence of transient arthralgias upon first IV exposure to the drug."5.10A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis. ( Aaron, SL; Chiu, P; Davis, P; Fitzgerald, AA; Homik, J; Jhangri, GS; LeClercq, S; Maksymowych, WP; Russell, AS; Sholter, D; Skeith, KJ; Yan, A, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maksymowych, WP1
Jhangri, GS1
Fitzgerald, AA1
LeClercq, S1
Chiu, P1
Yan, A1
Skeith, KJ1
Aaron, SL1
Homik, J1
Davis, P1
Sholter, D1
Russell, AS1

Trials

1 trial available for pamidronate and Muscle Disorders

ArticleYear
A six-month randomized, controlled, double-blind, dose-response comparison of intravenous pamidronate (60 mg versus 10 mg) in the treatment of nonsteroidal antiinflammatory drug-refractory ankylosing spondylitis.
    Arthritis and rheumatism, 2002, Volume: 46, Issue:3

    Topics: Adult; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Diphosphonates

2002